Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer

BACKGROUND: Breast cancer stem cells (BCSCs) have been suggested to have clinical implications for cancer therapeutics because of their proposed role in chemoresistance. The aim of this study was to investigate the impact of BCSC marker expression on clinical outcome and trastuzumab response in huma...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Seo, An Na, Lee, Hee Jin, Kim, Eun Joo, Jang, Min Hye, Kim, Yu Jung, Kim, Jee Hyun, Kim, Sung-Won, Ryu, Han Suk, Park, In Ae, Im, Seock-Ah, Gong, Gyungyub, Jung, Kyung Hae, Kim, Hee Jeong, Park, So Yeon
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2016
Témata:
Translational Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4865964/
https://ncbi.nlm.nih.gov/pubmed/27115469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.101
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky